|
2023
|
Invention
|
Hiv treatment compositions and methods. HIV treatment, and especially treatment of latent infecte... |
|
2020
|
Invention
|
Screening of cell clones expressing polygenic transgenes through non-antibiotic dependent positiv... |
|
|
Invention
|
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment. A... |
|
|
Invention
|
In-vitro car cytotoxicity and adcc validation. Artificial target cells lines with improved distin... |
|
|
Invention
|
Antibody pre-loaded cd16+nk-92 cells as an effective therapeutic product for tumor lysis. Provide... |
|
|
Invention
|
Compositions comprising aldoxorubicin hydrochloride and ifosfamide and their use for the treatmen... |
|
|
Invention
|
Recombinant eril-15 nk cells. Systems and methods are presented that provide for improved NK cell... |
|
|
Invention
|
Elimination of bcma-positive malignancies by car expressing nk cells. Provided are genetically mo... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors. Provided ar... |
|
2019
|
Invention
|
Primary nk car constructs and methods. Disclosed herein are recombinant nucleic acids, comprising... |
|
|
Invention
|
Il-2 dependent nk-92 cells with stable fc receptor expression. Provided herein are populations of... |
|
|
Invention
|
Anti-b7-h4 chimeric antigen receptor-modified nk-92 cells. Recombinant NK cells, and particularly... |
|
|
Invention
|
Elimination of pd-l1-positive malignancies by pd-l1 chimeric antigen receptor-expressing nk cells... |
|
|
Invention
|
Elimination of cd19-positive lymphoid malignancies by cd19-car expressing nk cells. Provided here... |
|
|
Invention
|
Combined invasion and cytotoxicity assay using chemokine secreting target cells. Provided herein ... |
|
|
Invention
|
A quadricistronic system comprising a homing receptor or a cytokine, and chimeric antigen recepto... |
|
|
Invention
|
Cryopreservation. Provided herein are methods and medium compositions for cryopreserving NK-92® c... |
|
|
Invention
|
Mononuclear cell derived nk cells. Cord blood or peripheral blood NK cells are prepared from whol... |
|
|
Invention
|
Ciml nk cells and methods therefor. Cytokine induced memory like (CIML) NK cells with enhanced cy... |
|
|
Invention
|
Generating cik nkt cells from cord blood. Provided herein are methods and customized media compos... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells. Provided are NK-92 cells expressing a chimeric an... |
|
|
Invention
|
Methods and systems for cell bed formation during bioprocessing. Methods and systems are disclose... |
|
|
Invention
|
Optimization of nk-92 cell growth using poloxamer. Provided herein are methods of culturing NK-92... |
|
|
Invention
|
Fc-epsilon car. Recombinant NK cells, and especially recombinant NK-92 cells express a chimeric a... |
|
|
Invention
|
Basal media for growing nk-92 cells.
Provided herein are methods and customized media compositio... |
|
|
Invention
|
Basal media for growing nk-92 cells. Provided herein are methods and customized media composition... |
|
|
Invention
|
Use of cd33car modified high affinity nk cells (t-hank) to reduce myeloid-derived suppressor cell... |
|
|
Invention
|
Use of 5% human albumin in wash and harvest media. Provided herein are methods of harvesting NK-9... |
|
2018
|
Invention
|
Nk-92 cells to stimulate anti-cancer vaccine. Provided herein are methods for inducing and mainta... |
|
|
Invention
|
Treating and inhibiting leukemia with nk-92 cells.
Described herein are methods for treating or ... |
|
|
Invention
|
Treating and inhibiting leukemia with nk-92 cells. Described herein are methods for treating or p... |
|
|
Invention
|
Chemokine responsive activated natural killer cells with secondary homing activation for verified... |
|
|
Invention
|
Methods for treating merkel cell carcinoma (mcc) using nk-92 cells. Provided herein are methods o... |
|
|
Invention
|
Nk-92 cells and il-15 agonist combination therapy. Provided herein are methods of treating merkel... |
|
|
Invention
|
Anti-egfr/high affinity nk-cells compositions and methods for chordoma treatment. Chordoma is tre... |
|
|
Invention
|
Ank and il-12 compositions and methods.
Contemplated treatment compositions and methods are dire... |
|
|
Invention
|
Modified nk-92 hank003 cells for the clinic. Provided herein are populations of modified NK-92 ce... |
|
|
Invention
|
Genetically modified nk-92 cells with decreased cd96/tigit expression. Provided are CD96-modified... |
|
2017
|
Invention
|
Hla class i-deficient nk-92 cells with decreased immunogenicity. Described herein are modified NK... |
|
|
Invention
|
Hdac inhibitors for use with nk cell based therapies. Provided are methods and compositions for t... |
|
2016
|
Invention
|
Compositions and methods for treatment of her2 positive metastatic breast cancer. Contemplated im... |
|
|
Invention
|
Modified nk-92 cells for treating cancer. Provided herein are NK-92 cells expressing at least one... |
|
|
Invention
|
Nk-92 cells in combination therapy with cancer drugs.
This disclosure is directed to composition... |
|
|
Invention
|
Genetically modified nk-92 cells and monoclonal antibodies for the treatment of cancer. This inve... |
|
|
Invention
|
Nk-92 cells in combination therapy with cancer drugs. This disclosure is directed to compositions... |
|
2015
|
Invention
|
Treating viral hemorrhagic fever with nk-92 cells.
This disclosure is directed to treatment of a... |
|
|
Invention
|
Treating viral hemorrhagic fever with nk-92 cells. This disclosure is directed to treatment of a ... |
|
|
Invention
|
Treating solid tumours with nk-92 cells applied by microcatheter.
Disclosed herein are methods f... |
|
2014
|
Invention
|
Protocol and media for storage and transport of nk-92 cell line.
Described herein is a storage m... |
